Intravenous (IV) bortezomib infusion after non‐response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?. (11th March 2016) - Gozzetti, Alessandro; Candi, Veronica; Zuanelli Brambilla, Corrado; Papini, Giulia; Bocchia, Monica